000			02074 a2200577 4500
005			20250514053023.0
264		0	_c20030109
008			200301s 0 0 eng d
022			_a1524-4628
024	7		_a10.1161/01.str.0000043823.37955.fb _2doi
040			_aNLM _beng _cNLM
100	1		_aElting, Jan-Willem
245	0	0	_aAMPA antagonist ZK200775 in patients with acute ischemic stroke: possible glial cell toxicity detected by monitoring of S-100B serum levels. _h[electronic resource]
260			_bStroke _cDec 2002
300			_a2813-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Disease
650	0	4	_aAged
650	0	4	_aArea Under Curve
650	0	4	_aBiomarkers _xblood
650	0	4	_aBrain Ischemia _xblood
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aExcitatory Amino Acid Antagonists _xadverse effects
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNerve Growth Factors _xblood
650	0	4	_aNeuroglia _xdrug effects
650	0	4	_aOrganophosphonates _xadverse effects
650	0	4	_aPhosphopyruvate Hydratase _xblood
650	0	4	_aQuinoxalines _xadverse effects
650	0	4	_aReceptors, AMPA _xantagonists & inhibitors
650	0	4	_aRegression Analysis
650	0	4	_aS100 Calcium Binding Protein beta Subunit
650	0	4	_aS100 Proteins _xblood
650	0	4	_aSeverity of Illness Index
650	0	4	_aStroke _xblood
650	0	4	_aTreatment Outcome
700	1		_aSulter, Geert A
700	1		_aKaste, Markku
700	1		_aLees, Kennedy R
700	1		_aDiener, Hans C
700	1		_aHommel, Marc
700	1		_aVersavel, Mark
700	1		_aTeelken, Albert W
700	1		_aDe Keyser, Jacques
773	0		_tStroke _gvol. 33 _gno. 12 _gp. 2813-8
856	4	0	_uhttps://doi.org/10.1161/01.str.0000043823.37955.fb _zAvailable from publisher's website
999			_c12273924 _d12273924